Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3748718)

Published in Neurogastroenterol Motil on June 02, 2009

Authors

N Gathaiya1, G R Locke, M Camilleri, C D Schleck, A R Zinsmeister, N J Talley

Author Affiliations

1: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN and Mayo Clinic Florida, Jacksonville, FL 32224, USA.

Articles cited by this

History of the Rochester Epidemiology Project. Mayo Clin Proc (1996) 21.72

Functional gastroduodenal disorders. Gastroenterology (2006) 8.51

Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84

Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90

A patient questionnaire to identify bowel disease. Ann Intern Med (1989) 3.43

A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14

Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54

American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology (2005) 2.39

A study of candidate genotypes associated with dyspepsia in a U.S. community. Am J Gastroenterol (2006) 2.30

Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med (1976) 2.24

Sleep disturbances in clinic patients with functional bowel disorders. Am J Gastroenterol (2000) 1.96

Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol (1998) 1.96

Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol (1995) 1.94

Effect of sleep quality on symptoms of irritable bowel syndrome. Dig Dis Sci (1993) 1.86

Candidate genotypes associated with functional dyspepsia. Neurogastroenterol Motil (2008) 1.86

Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol (2001) 1.84

Diet and functional gastrointestinal disorders: a population-based case-control study. Am J Gastroenterol (2005) 1.84

A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol (2004) 1.75

Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc (2000) 1.64

Psychometric properties of the SUNYA revision of the Psychosomatic Symptom Checklist. J Behav Med (1984) 1.41

Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther (2007) 1.16

Prevalence, incidence and natural history of dyspepsia and functional dyspepsia. Baillieres Clin Gastroenterol (1998) 1.15

Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut (1994) 1.07

Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci (1994) 1.06

Subjective and objective sleep quality in irritable bowel syndrome. Am J Gastroenterol (1999) 1.06

Dietary factors in functional dyspepsia. Neurogastroenterol Motil (2006) 1.02

Genetics of irritable bowel syndrome. Am J Gastroenterol (2008) 0.98

Sleep and duodenal motor activity in patients with severe non-ulcer dyspepsia. Gut (1994) 0.98

Drug treatment of functional dyspepsia. Scand J Gastroenterol Suppl (1991) 0.86

Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups. Am J Gastroenterol (1994) 0.85

The sleeping gut. Med Clin North Am (1981) 0.80

Articles by these authors

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98

A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67

Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66

Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA (1998) 4.62

Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut (1990) 4.60

Simplified assessment of segmental colonic transit. Gastroenterology (1987) 4.59

Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23

Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16

A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology (1990) 4.02

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92

Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut (2008) 3.81

Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology (1990) 3.77

Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68

The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology (2001) 3.60

A patient questionnaire to identify bowel disease. Ann Intern Med (1989) 3.43

Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34

The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med (1997) 3.31

Optimal testing parameters for blood cultures. Clin Infect Dis (2004) 3.17

A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14

Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology (1989) 3.12

Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol (1999) 3.01

Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology (1996) 3.00

Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology (1993) 2.99

The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (2012) 2.96

Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89

Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut (2000) 2.86

Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut (2008) 2.82

Medical costs in community subjects with irritable bowel syndrome. Gastroenterology (1995) 2.81

Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med (1995) 2.78

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther (2013) 2.73

Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73

The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med (1995) 2.73

Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther (2005) 2.71

Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology (1997) 2.71

Review article: Associations between Helicobacter pylori and obesity--an ecological study. Aliment Pharmacol Ther (2014) 2.69

Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther (2014) 2.67

Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67

Comparison of LightCycler PCR, rapid antigen immunoassay, and culture for detection of group A streptococci from throat swabs. J Clin Microbiol (2003) 2.57

Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology (1990) 2.56

Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54

Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology (1993) 2.52

Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut (1987) 2.46

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol (1998) 2.38

Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther (2002) 2.37

Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther (2013) 2.36

Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35

Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther (2004) 2.35

Sex differences in evaluation and outcome of unstable angina. JAMA (2000) 2.33

Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology (1990) 2.32

Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther (2014) 2.30

Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28

Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil (2004) 2.28

A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27

Outcomes after curative resections of cholangiocarcinoma. Arch Surg (1993) 2.26

Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26

Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med (1982) 2.23

Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci (1989) 2.23

Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23

Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology (2001) 2.22

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22

Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology (1992) 2.17

Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Aliment Pharmacol Ther (2015) 2.17

Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther (2004) 2.13

Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2015) 2.13

Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12

Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology (1994) 2.12

Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil (2014) 2.11

Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology (1990) 2.09

Severe exercise-induced ischemia does not identify high risk patients with normal left ventricular function and one- or two-vessel coronary artery disease. J Am Coll Cardiol (1994) 2.08

Clinical predictors of recurrent Clostridium difficile infection in out-patients. Aliment Pharmacol Ther (2014) 2.08

Prospective comparison of endoscopy patient satisfaction surveys: e-mail versus standard mail versus telephone. Am J Gastroenterol (2001) 2.08

The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther (2014) 2.05

Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut (2001) 2.05

Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology (1986) 2.03

What prognostic factors are important in duodenal adenocarcinoma? Arch Surg (2000) 2.03

Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol (1996) 2.01

The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol (1985) 2.01

Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol (1995) 1.99

Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil (2007) 1.98

Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology (1991) 1.98

Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol (1998) 1.96

Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol (1995) 1.94

Predictors of outcome after percutaneous endoscopic gastrostomy: a community-based study. Mayo Clin Proc (1992) 1.94

Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol (2000) 1.93

Lipoprotein analysis in the evaluation of chest pain in the emergency department. Mayo Clin Proc (1991) 1.92